Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/2003
03/27/2003US20030059439 Th1 inducing natural adjuvant for heterologous antigens
03/27/2003US20030059433 Screening at least one individual for a mutation in a gene coding for a Poly-Ig (Fc) receptor or a Poly-Ig-like (Fc) receptor capable of mediating inhibition of cancer cell growth by an immunoglobulin inhibitor
03/27/2003US20030059432 Lipophilin complexes for use in cancer diagnosis and therapy
03/27/2003US20030059431 Prostatic growth factor
03/27/2003US20030059429 Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders
03/27/2003US20030059428 Treatment of autoimmune diseases
03/27/2003US20030059427 Isolation and characterization of highly active anti-CD40 antibody
03/27/2003US20030059425 Inhibitory immunoglobulin polypeptides to human pdgf beta receptor
03/27/2003US20030059424 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
03/27/2003US20030059423 Method for treating symptoms of diabetes
03/27/2003US20030059417 Methods and compositions for diagnosing and treating disorders involving angiogenesis
03/27/2003US20030059338 Protecting from contaminants or pathogens with irradiation; biological sample is immunoglobulin, thrombin enzyme, antihemophilic factor, urokinase
03/27/2003US20030058406 Method for refracting and dispensing electro-active spectacles
03/27/2003US20030056700 Ultra fine fly ash and a system for collecting the same
03/27/2003CA2708411A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2708349A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2461065A1 Transductin-1 and transductin-2 and applications to hereditary deafness
03/27/2003CA2460812A1 Lipid-associated molecules
03/27/2003CA2460808A1 Immune response associated proteins
03/27/2003CA2460587A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003CA2460568A1 Preparation of highly-purified plasma membranes
03/27/2003CA2460558A1 Crustaceans as production systems for therapeutic proteins
03/27/2003CA2460392A1 Recombinant allergen with reduced ige binding but undiminished t-cell antigenicity
03/27/2003CA2460372A1 Lactobacillus n-deoxyribosyl transferases, corresponding nucleotide sequences and their uses
03/27/2003CA2460120A1 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003CA2459587A1 Activation and expansion of cells
03/27/2003CA2459219A1 Methods of diagnosis of cancer compositions and methods of screening for modulators of cancer
03/27/2003CA2459140A1 Protein modification and maintenance molecules
03/27/2003CA2459022A1 Neurotransmission-associated proteins
03/27/2003CA2452288A1 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003CA2445205A1 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/26/2003WO2002026978A1 Novel proteins, genes encoding them and method of using the same
03/26/2003EP1295939A1 Insulin-like growth factor binding protein
03/26/2003EP1295895A1 Peptides and Protins binding to glu-pro motifs, therapeutical compositions containing them and their applications
03/26/2003EP1295606A1 Curing method for pathologic syndrome and a medicinal preparation
03/26/2003EP1295127A2 Inter-alpha-trypsin as a marker for sepsis
03/26/2003EP1294949A2 Human tumor necrosis factor delta and epsilon
03/26/2003EP1294928A1 Screening method for modulators of suv39h2-methyltransferase
03/26/2003EP1294927A1 Screening-method for modulators of methyltransferase-dependent chromosome stability
03/26/2003EP1294904A1 Heterodimeric fusion proteins
03/26/2003EP1294901A2 Novel proteases
03/26/2003EP1294895A2 Calpain protease 12
03/26/2003EP1294891A2 Transport peptides derived from erns protein, cytotoxic rnase of ribosome-inactivating protein or a rsv g-protein and analogues thereof
03/26/2003EP1294890A2 Peptides for the preparation of vaccines against bordetella pertussis and bordetella parapertussis
03/26/2003EP1294888A2 Interferon-like protein zcyto21
03/26/2003EP1294887A1 Insulin homolog polypeptide zins4
03/26/2003EP1294886A2 THREE-DIMENSIONAL MODEL OF A Fc REGION OF AN IGE ANTIBODY AND USES THEREOF
03/26/2003EP1294885A2 B7-like molecules and uses thereof
03/26/2003EP1294884A2 Secretion and trafficking molecules
03/26/2003EP1294883A2 Human extracellular matrix (ecm)-related tumor marker
03/26/2003EP1294882A2 B7-like molecules and uses thereof
03/26/2003EP1294879A2 Thymic stromal lymphopoietin receptor molecules and uses thereof
03/26/2003EP1294876A2 Eg-vegf nucleic acids and polypeptides and methods of use
03/26/2003EP1294873A1 Tumour suppressor and uses thereof
03/26/2003EP1294871A1 Secreted epithelial colon stromal-1 polypeptides, nucleic acids encoding the same and uses thereof
03/26/2003EP1294868A2 Adenylyl and guanylyl cyclases
03/26/2003EP1294856A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE
03/26/2003EP1294770A1 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system
03/26/2003EP1294769A1 Antibodies that immunospecifically bind to blys
03/26/2003EP1294765A2 Il-17 molecules and uses thereof
03/26/2003EP1294764A2 Human receptors
03/26/2003EP1294755A2 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
03/26/2003EP1294754A1 Interferon-alpha induced gene
03/26/2003EP1294753A2 A human homologue of the db4/ask1 protein, nucleic acids, and methods related to the same
03/26/2003EP1294752A2 Angiogenesis-modulating compositions and uses
03/26/2003EP1294751A1 Dermacentor variabilis gaba-gated chloride channels
03/26/2003EP1294746A1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains
03/26/2003EP1294401A2 Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enhancing agents
03/26/2003EP1294398A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294397A2 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
03/26/2003EP1294391A2 Methods for regulating a cell-mediated immune response by blocking lymphocytic signals and by blocking lfa-1 mediated adhesion
03/26/2003EP0939809B1 Tie-2 receptor ligand (tie ligand-4) and its use
03/26/2003EP0871484B1 Prophylactic immune milk preparation against otitis
03/26/2003EP0835261B1 Ion channel
03/26/2003EP0759037B1 Antigen/antibody specificity exchanger
03/26/2003EP0625159B1 Ikaros: a regulatory gene involved in t-cell differentiation
03/26/2003EP0610436B9 Hepatitis-c virus testing
03/26/2003EP0261224B2 Synthetic htlv-iii peptides, compositions and uses thereof
03/26/2003CN1406279A Antibody for detecting mycoplasma pheumoniae
03/26/2003CN1406249A Enhancing the circulating half-life of antibody-based fusion proteins
03/26/2003CN1406248A Antibody for de tecting chlamydia pheumoniae
03/26/2003CN1406138A Modified antibodies and antibody fragments with increased duration of activity
03/26/2003CN1406137A Caspase activated prodrugs therapy
03/26/2003CN1406136A Novel antibody with specificity for colon cancer
03/26/2003CN1405563A Method and kit for detecting and determining beta-lactam penicillin
03/26/2003CN1405180A Chemotactic factor beta-8 short type
03/26/2003CN1404877A Blood-platelet specific mosaic immune globulin and its using method
03/26/2003CN1404876A Use of anti-CTLA anti-body
03/26/2003CN1103820C Method for detection of methylthioadenosine phosphorylase deticiency in mammallian cells
03/26/2003CN1103812C Human beta-2 integrin alpha subunit
03/26/2003CN1103782C Mono-pegylated MGDF polypeptide
03/26/2003CA2423858A1 Novel proteins, genes encoding them and method of using the same
03/25/2003US6538126 Polynucleotides of given sequence derived from CDNA
03/25/2003US6538124 Polypeptide variants
03/25/2003US6538121 Interleukin-1 β converting enzyme like apoptosis protease-3 and 4
03/25/2003US6538114 Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen
03/25/2003US6538113 Methods of obtaining antibody directed against prothrombin fragments F2/F1+2
03/25/2003US6538112 Hybridomas and monoclonal antibodies for an anticoagulant test
03/25/2003US6538111 Monoclonal, humanized antibodies; hybridomas; transformants; use in diagnosis and treatment of chronic bronchial asthma
03/25/2003US6538110 Monoclonal antibodies against the interleukin 2 receptor
1 ... 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 ... 1494